临床IA期肺癌肺叶切除与肺段切除生存等效
基于STS数据库与Medicare数据链接,纳入2002至2015年14286例临床IA期肺癌患者,其中肺段切除1654例、肺叶切除12632例。
要点
- 临床IA期肺癌肺段切除与肺叶切除长期生存相似(HR 1.04,95%CI 0.89-1.20)
- 2009-2015年亚组分析结果一致(HR 1.00,95%CI 0.87-1.16)
- STS数据库外科医生对亚肺叶切除患者选择适当
核心结论
- 对于早期肺癌,肺叶切除与肺段切除是同等有效的治疗方式,生存相似。
- STS数据库的外科医生似乎正在适当地为患者选择亚肺叶切除手术。
研究设计与样本
- STS通用胸外科数据库与Medicare数据链接,纳入2002至2015年临床IA期(T1N0)肺癌患者14286例,其中肺段切除1654例、肺叶切除12632例。
- 采用Cox回归建立长期生存模型,并按人口学和临床变量进行倾向性匹配。
主要发现
- 在匹配子队列中,肺段切除与肺叶切除的生存也相似。
- 限制于2009至2015年人群(n=11811)的亚组分析显示,肺段切除与肺叶切除的生存仍相似(HR 1.00,95%CI 0.87-1.16)。
- 对病理N0患者的亚组分析显示了相同的结果。
关键数值与推荐
- 2009-2015年亚组肺段切除 vs 肺叶切除的HR为1.00(95%CI 0.87-1.16)。
临床怎么用
- 对于临床IA期肺癌,肺段切除可作为与肺叶切除等效的治疗选择。
- 外科医生应根据患者情况适当选择亚肺叶切除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The oncologic efficacy of segmentectomy is controversial. We compared long-term survival in clinical stage IA (T1N0) Medicare patients undergoing lobectomy and segmentectomy in The Society of Thoracic Surgeons database. METHODS: The Society of Thoracic Surgeons General Thoracic Surgery Database was linked to Medicare data in 14,286 lung cancer patients who underwent segmentectomy (n = 1654) or lobectomy (n = 12,632) for clinical stage IA disease from 2002 to 2015. Cox regression was used to create a long-term survival model. Patients were then propensity matched on demographic and clinical variables to derive matched pairs. RESULTS: In Cox modeling segmentectomy was associated with survival similar to lobectomy in the entire cohort (hazard ratio, 1.04; 95% confidence interval, 0.89-1.20; P = .64) and in the matched subcohort. A subanalysis restricted to the 2009 to 2015 population (n = 11,811), when T1a tumors were specified and positron emission tomography results and mediastinal staging procedures were accurately recorded in the database, also showed that segmentectomy and lobectomy continue to have similar survival (hazard ratio, 1.00; 95% confidence interval, 0.87-1.16). Subanalysis of the pathologic N0 patients demonstrated the same results. CONCLUSIONS: Lobectomy and segmentectomy for early-stage lung cancer are equally effective treatments with similar survival. Surgeons from The Society of Thoracic Surgeons database appear to be selecting patients appropriately for sublobar procedures.
引用
- Onaitis MW, Furnary AP, Kosinski AS, et al. Equivalent Survival Between Lobectomy and Segmentectomy for Clinical Stage IA Lung Cancer. Ann Thorac Surg. 2020. PMID: 32119855. doi:10.1016/j.athoracsur.2020.01.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。